Chitosan microcapsule and its preparation method and uses
A technology of chitosan and chitosan solution, applied in the field of chitosan, can solve the problems of large particle size of chitosan microcapsules, unfavorable drug controlled release, loose microcapsule structure, etc. Cytotoxic, easy-to-process effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Dissolve chitosan in 0.2mol / L acetic acid solution to prepare a 2% (w / v) solution, take 50mL liquid paraffin and add it to the reactor, add 1mL span 80, stir, the speed is 1500 rpm, and disperse After 10 minutes, add 10 mL of chitosan solution and continue to stir and disperse for 20 minutes, then add 50 mL of acetone dissolved in 200 mg of vanillin for cross-linking reaction, and stop after 1 hour. The reaction mixture was centrifuged, the reaction product was fully washed with petroleum ether, and the microcapsules were obtained after vacuum drying at room temperature. It can be used to embed proteins, polypeptide active macromolecular drugs and common drugs for colon targeted drug delivery.
Embodiment 2
[0035]Chitosan was dissolved in 0.2mol / L acetic acid solution to prepare a 3% (w / v) solution, 100mg naproxen was dispersed in the above 10mL chitosan solution, stirred, and 50mL liquid paraffin was added to the reactor In the process, continue stirring at a speed of 1000 rpm. After 20 minutes, add 60 mL of acetone dissolved in 1 g of vanillin for cross-linking, and stop the reaction after 1.5 hours. The reaction mixture is centrifuged, and the reaction product is fully washed with sherwood oil, and after vacuum drying at room temperature, the chitosan microcapsules embedded with naproxen are obtained, and the microcapsule particle diameter is about 750um (such as figure 1 ). The release profile of the microcapsules in a pH=5 buffer solution simulating the colonic environment is as follows: image 3 As shown, the microcapsule has the effect of colon-targeted drug release control.
Embodiment 3
[0037] Chitosan was dissolved in 0.2mol / L acetic acid solution to prepare a 3% (w / v) solution, 100mg naproxen was dispersed in the above 10mL chitosan solution, stirred, and 50mL liquid paraffin was added to the reactor Add 1mL span 80, add the above dispersion system, continue stirring at 1000 rpm, after 20 minutes, add 60mL acetone dissolved in 1g vanillin for cross-linking, and stop the reaction after 1.5 hours. The reaction mixture is centrifuged, and the reaction product is fully washed with sherwood oil, and after vacuum drying at room temperature, the chitosan microcapsules embedded with naproxen are obtained, and the microcapsule particle diameter is about 430um (such as figure 2 ). The release profile of the microcapsules in a pH=5 buffer solution simulating the colonic environment is as follows: Figure 4 It shows that the microcapsule has the effect of colon-targeted drug release control.
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com